ProGenis Pharmaceuticals, a leader in innovative scientific solutions, is proud to announce the appointment of Dr. Sudhir Agrawal as the new Chair of its Scientific Advisory Board. Dr. Agrawal brings with him a wealth of experience and a remarkable track record in the biopharmaceutical and RNA technology sectors.
Dr. Agrawal is the Founder and President of ARNAY Sciences LLC, a position that highlights his entrepreneurial spirit and commitment to advancing cutting-edge scientific research. His expertise spans decades of leadership, having founded Idera Pharmaceuticals and held key roles such as Chairman, CEO, President of Research, and Chief Scientific Officer. His contributions to the field have been nothing short of transformative, particularly in the realms of oligonucleotides and antisense technology.
Beyond his entrepreneurial accomplishments, Dr. Agrawal is a respected academic, serving as a Visiting Professor in the Department of Medicine at The University of Massachusetts Medical School. He is also a member of the Business Advisory Board of The Harvard Medical School’s Initiative for RNA Medicine, reinforcing his profound influence on the scientific community.
Dr. Agrawal’s prolific output as a researcher is evidenced by his authorship of more than 300 published papers. His innovative work has also led to the co-invention of over 400 patents worldwide. In addition to his academic achievements, he has edited four important books on oligonucleotides and antisense technology, further cementing his status as a thought leader in his field.
At ProGenis Pharmaceuticals, Dr. Agrawal’s invaluable guidance will steer the company toward new heights of scientific advancement. With his vast knowledge and experience, we are confident that his leadership will drive innovation and contribute to the ongoing success of our mission to push the boundaries of scientific discovery.
We are excited to welcome Dr. Sudhir Agrawal to the ProGenis Pharmaceuticals family and look forward to his insights as we continue to pioneer the future of science and technology.